23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg
Por um escritor misterioso
Descrição
CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone.
IMG_LA-GettyImages-49653_2_1_61427S0V.jpg
23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg
FDA clears 23andMe's DTC drug metabolism test
23andMe Is Bringing DNA Sequencing for Health Risks To Consumers - Bloomberg
The FDA Just Ruined Your Plans To Buy 23andMe's DNA Test As A Christmas Present
What we know about the 23andMe data breach - San Francisco Business Times
DNA-Tester 23andMe Starts Trial of First Drug Developed In-House - BNN Bloomberg
23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg
Pharmacy Benefit Managers, Pharmacies, and Pharmacogenomic Testing: Prescription for Progress?
23andMe Trials-in-Progress Poster Details Expansion Cohorts for 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer's (SITC) 2022 Annual Meeting
23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg
23andMe jumps into telehealth, prescription drug delivery with $400M buyout of Lemonaid Health
23andMe to Get a Makeover After Agreement with FDA
Drugmakers plan to pay $20M for DNA from 23andMe customers
de
por adulto (o preço varia de acordo com o tamanho do grupo)
